SEC mulls changes to ETF oversight framework
Investing.com -- The US Securities and Exchange Commission published a request for comment Tuesday on potential changes to its oversight of exchange-traded funds, examining whether its regulatory approach remains appropriate for the $16 trillion industry.
The agency is seeking feedback on several areas, including whether ETF filers should receive greater confidentiality during the review process. The current system makes submissions public immediately, allowing competing firms to quickly file similar applications.
The SEC is also asking whether additional circumstances should exist under which it could suspend the effectiveness of an ETF's registration or intervene after a fund becomes effective. Under the existing framework, the agency does not formally approve or reject ETFs, with its primary enforcement mechanisms largely limited to suspending the effectiveness of ETF shares.
Respondents have 60 days to submit comments.
The review follows a recent wave of filings for prediction-market ETFs, which prompted fresh examination of the regulatory framework. In May, SEC Chairman Paul Atkins directed staff to seek public input on these products, which would allow investors to bet on outcomes of events ranging from elections to economic data releases.
The confidentiality question stems from concerns about the current filing process, where public submissions enable firms to race for first-mover advantages. The agency faced challenges during the 2024 rollout of crypto-tied funds, when firms competed for early market entry.
The comment process does not guarantee new rules will be implemented. The agency could address identified issues through measures such as exemptive relief or staff no-action letters.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NPR retracts story about Justice Alito retiring from Supreme Court
- Ecovyst completes acquisition of Calabrian from Ineos Enterprises
- Quoin Pharmaceuticals receives U.S. patent allowance for Netherton drug
Create E-mail Alert Related Categories
InvestingRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share